Chemotherapy News and Research

Latest Chemotherapy News and Research

Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

A new molecule has been found that protects the heart from toxic breast cancer drugs and also kills the cancerous tumour. The research from Italy addresses the burgeoning problem of heart disease in cancer survivors and is announced by the European Society of Cardiology today on World Cancer Day.

4 Feb 2015

New drug gets FDA approval for treatment of women with advanced breast cancer

The U.S. Food and Drug Administration today approved a potentially groundbreaking new drug to treat women with advanced breast cancer, signaling a new treatment strategy to arrest tumor growth and extend the time before the cancer worsens.

4 Feb 2015

New study identifies three genes that enable glioblastoma to recur, progress after radiation therapy

A new study identifies three genes that together enable a lethal form of brain cancer to recur and progress after radiation therapy.

4 Feb 2015

Class-action lawsuit filed against Health Net for misrepresenting physician and hospital networks

In advance of a California legislative hearing on health care "costs" not scheduled to include testimony from consumers, consumer advocates will discuss the real financial threat patients face in a class-action lawsuit against Health Net for misrepresenting their physician and hospital networks.

4 Feb 2015

Research describes new way of shrinking ovarian cancer tumors, improving drug delivery

New research published in the February 2015 issue of The FASEB Journal, may eventually help improve the five-year survival rate of ovarian cancer patients by describing a new way of shrinking ovarian cancer tumors while also simultaneously improving drug delivery.

3 Feb 2015

Dartmouth scientists discover novel cancer resistance mechanism

In the search for new approaches to treat ERBB2 (also known as HER2) positive breast cancers that have become drug-resistant, Dartmouth's Norris Cotton Cancer Center investigator Manabu Kurokawa, PhD, led a team in discovery of a novel cancer resistance mechanism with findings published in Cell Cycle.

3 Feb 2015

Janssen granted Priority Review from FDA for YONDELIS (trabectedin) NDA to treat STS patients

Janssen Research & Development, LLC announced today that the U.S. Food and Drug Administration has granted Priority Review for the New Drug Application (NDA) for YONDELIS (trabectedin) to treat patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.

3 Feb 2015

NQMBC recognizes Cancer Treatment Centers of America for providing quality breast cancer care

Cancer Treatment Centers of America at Midwestern Regional Medical Center has been recognized by the National Quality Measures for Breast Centers Program as being among the top centers in the country for providing quality breast cancer care.

3 Feb 2015

Two new fluorescent dyes may help localize, resect brain tumors

Two new fluorescent dyes attracted to cancer cells may help neurosurgeons more accurately localize and completely resect brain tumors, suggests a study in the February issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

2 Feb 2015

Study examines why hydroxyurea yields mixed results in children with sickle cell disease

Electronic medication monitoring caps may help physicians put together the puzzle of why children taking a medicine that promises to curb sickle cell disease are showing mixed, confusing results.

2 Feb 2015

Mathematical models of cancer behavior offer new insights on tumor growth

Hassan Fathallah-Shaykh, M.D., Ph.D., believes that math can transform medicine, and he has the numbers to prove it.

2 Feb 2015

Study identifies genetic basis of drug toxicity in leukemia patients of East Asian ancestry

January 26, 2015) About 10 percent of young leukemia patients of East Asian ancestry inherit a gene variation that is associated with reduced tolerance of a drug that is indispensable for curing acute lymphoblastic leukemia (ALL), the most common childhood cancer.

2 Feb 2015

Two researchers receive Charles Rodolphe Brupbacher Prize for Cancer Research

Researchers Irving L. Weissman and Joan Massagué have won this year's Charles Rodolphe Brupbacher Prize for Cancer Research: Weissman, from Stanford University, for his work on healthy and sick stem cells; Massagué, from Memorial Sloan Kettering Cancer Center in New York, for his research on metastatic spread.

31 Jan 2015

Damon Runyon Cancer Research Foundation names 15 new Damon Runyon Fellows

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named 15 new Damon Runyon Fellows at its fall Fellowship Award Committee review. The recipients of this prestigious, four-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country.

31 Jan 2015

NCCN commemorates 20 years of advancing high-quality, high-value cancer care

On January 31, 2015, the National Comprehensive Cancer Network celebrates its 20th anniversary. Originally announced as an alliance of 13 leading cancer centers in 1995, NCCN has grown to a network of 25 academic cancer centers; the NCCN mission as an alliance of leading academic cancer centers devoted to patient care, research, and education, is to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives.

31 Jan 2015

Multiplexed testing for EGFR and ALK gene rearrangements may be cost-effective for NSCLC treatment

Multiplexed genetic screening for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) gene rearrangements and subsequent biomarker-guided treatment is cost-effective compared with standard chemotherapy treatment without any molecular testing in the metastatic non-small cell lung cancer (NSCLC) setting in the United States.

31 Jan 2015

FDA’s approval of ibrutinib to treat Waldenstrom's macroglobulinemia receives praises from LLS

The U.S. Food and Drug Administration approval of ibrutinib (Imbruvica) to treat patients with Waldenstrom's macroglobulinemia(WM) is a significant advance for patients with this rare blood cancer.

31 Jan 2015

Pancreatic cancer cells know a way to sidestep chemotherapy, reveal Fox Chase researchers

Pancreatic cancer is one of the deadliest forms of the disease. The American Cancer Society's most recent estimates for 2014 show that over 46,000 people will be diagnosed with pancreatic cancer and more than 39,000 will die from it. Now, research led by Timothy J. Yen, PhD, Professor at Fox Chase Cancer Center, reveals that one reason this deadly form of cancer can be so challenging to treat is because its cells have found a way to sidestep chemotherapy.

30 Jan 2015

Scientists identify strong link between beclin 1 gene and triple-negative breast cancer

UT Southwestern Medical Center scientists have identified a strong link between the most aggressive type of breast cancer and a gene that regulates the body's natural cellular recycling process, called autophagy.

30 Jan 2015

Researchers identify molecular pathways that could lead to new therapeutic targets for cerebral malaria

A drug already approved for treating other diseases may be useful as a treatment for cerebral malaria, according to researchers at Harvard T. H. Chan School of Public Health. They discovered a novel link between food intake during the early stages of infection and the outcome of the disease, identifying two molecular pathways that could serve as new targets for treatment.

30 Jan 2015

Chemotherapy News and Research

Latest Chemotherapy News and Research

Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

New drug gets FDA approval for treatment of women with advanced breast cancer

New study identifies three genes that enable glioblastoma to recur, progress after radiation therapy

Class-action lawsuit filed against Health Net for misrepresenting physician and hospital networks

Research describes new way of shrinking ovarian cancer tumors, improving drug delivery

Dartmouth scientists discover novel cancer resistance mechanism

Janssen granted Priority Review from FDA for YONDELIS (trabectedin) NDA to treat STS patients

NQMBC recognizes Cancer Treatment Centers of America for providing quality breast cancer care

Two new fluorescent dyes may help localize, resect brain tumors

Study examines why hydroxyurea yields mixed results in children with sickle cell disease

Mathematical models of cancer behavior offer new insights on tumor growth

Study identifies genetic basis of drug toxicity in leukemia patients of East Asian ancestry

Two researchers receive Charles Rodolphe Brupbacher Prize for Cancer Research

Damon Runyon Cancer Research Foundation names 15 new Damon Runyon Fellows

NCCN commemorates 20 years of advancing high-quality, high-value cancer care

Multiplexed testing for EGFR and ALK gene rearrangements may be cost-effective for NSCLC treatment

FDA’s approval of ibrutinib to treat Waldenstrom's macroglobulinemia receives praises from LLS

Pancreatic cancer cells know a way to sidestep chemotherapy, reveal Fox Chase researchers

Scientists identify strong link between beclin 1 gene and triple-negative breast cancer

Researchers identify molecular pathways that could lead to new therapeutic targets for cerebral malaria

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in